- Home
- VOR vs PFD Comparison
VOR vs PFD Comparison
Compare VOR & PFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- PFD
- Stock Information
- Founded
- VOR 2015
- PFD 1990
- Country
- VOR United States
- PFD United States
- Employees
- VOR N/A
- PFD N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- PFD Investment Managers
- Sector
- VOR Health Care
- PFD Finance
- Exchange
- VOR Nasdaq
- PFD Nasdaq
- Market Cap
- VOR 161.9M
- PFD 147.0M
- IPO Year
- VOR 2021
- PFD N/A
- Fundamental
- Price
- VOR $1.37
- PFD $11.29
- Analyst Decision
- VOR Strong Buy
- PFD
- Analyst Count
- VOR 7
- PFD 0
- Target Price
- VOR $11.36
- PFD N/A
- AVG Volume (30 Days)
- VOR 419.2K
- PFD 33.2K
- Earning Date
- VOR 03-19-2025
- PFD 01-01-0001
- Dividend Yield
- VOR N/A
- PFD 6.30%
- EPS Growth
- VOR N/A
- PFD N/A
- EPS
- VOR N/A
- PFD N/A
- Revenue
- VOR N/A
- PFD N/A
- Revenue This Year
- VOR N/A
- PFD N/A
- Revenue Next Year
- VOR N/A
- PFD N/A
- P/E Ratio
- VOR N/A
- PFD N/A
- Revenue Growth
- VOR N/A
- PFD N/A
- 52 Week Low
- VOR $0.63
- PFD $8.53
- 52 Week High
- VOR $2.43
- PFD $11.18
- Technical
- Relative Strength Index (RSI)
- VOR 50.68
- PFD 47.67
- Support Level
- VOR $1.36
- PFD $11.34
- Resistance Level
- VOR $1.50
- PFD $11.46
- Average True Range (ATR)
- VOR 0.11
- PFD 0.10
- MACD
- VOR -0.01
- PFD 0.00
- Stochastic Oscillator
- VOR 37.50
- PFD 66.67
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.
About PFD Flaherty & Crumrine Preferred and Income Fund Incorporated
Flaherty & Crumrine Prefd Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities, which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.